Prevention of hepatitis B and C in the EU/EEA and the UK
Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.
The sustainable development goals and hepatitis B and C in the EU/EEA
In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.
Hepatitis A virus in the EU/EEA, 1975–2014
A systematic review of seroprevalence and incidence comprising European surveillance data and national vaccination recommendations. This report provides a comprehensive picture of Hepatitis A virus (HAV) infection epidemiology in the EU/EEA between 1975 and 2014.